Characterization of cationic lipid-protamine–DNA (LPD) complexes for intravenous gene delivery (original) (raw)
- Paper
- Published: 10 July 1998
Gene Therapy volume 5, pages 930–937 (1998)Cite this article
- 2337 Accesses
- 3 Altmetric
- Metrics details
Abstract
A previous study has shown an efficient, systemic transgene expression in mice via intravenous administration of a LPD formulation composed of DOTAP liposomes, protamine sulfate and plasmid DNA. In this study, factors affecting the in vivo performance of this formulation were further evaluated. A protocol in which liposomes were mixed with protamine before the addition of plasmid DNA was shown to produce small condensed particles with a diameter of about 135 nm. These particles were stable over time and gave a high level of gene expression in all tissues examined including lung, heart, spleen, liver and kidney with the highest level of expression in the lung. Inclusion of dioleoylphosphatidylethanolamine (DOPE) as a helper lipid significantly decreased the in vivo activity of LPD. In contrast, inclusion of cholesterol as a helper lipid increased the in vivo transfection efficiency of LPD and more importantly, decrease the amount of cationic lipid required for the maximal level of gene expression. Studies on the interaction between mouse serum and LPD showed that LPD became negatively charged after exposure to serum, and LPDs containing different helper lipids varied in the amount of associated serum proteins. LPD containing DOPE was more enriched in a protein corresponding to albumin in molecular weight. These results suggest that the mechanism of LPD-mediated intravenous gene delivery might be different from that of in vitro lipofection and that serum protein association might be a major factor limiting the in vivo transfection by LPD.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 6 print issues and online access
$259.00 per year
only $43.17 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Additional access options:
Similar content being viewed by others
Author information
Authors and Affiliations
- Department of Pharmacology, Laboratory of Drug Targeting, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA
S Li, MA Rizzo, S Bhattacharya & L Huang
Authors
- S Li
You can also search for this author inPubMed Google Scholar - MA Rizzo
You can also search for this author inPubMed Google Scholar - S Bhattacharya
You can also search for this author inPubMed Google Scholar - L Huang
You can also search for this author inPubMed Google Scholar
Rights and permissions
About this article
Cite this article
Li, S., Rizzo, M., Bhattacharya, S. et al. Characterization of cationic lipid-protamine–DNA (LPD) complexes for intravenous gene delivery.Gene Ther 5, 930–937 (1998). https://doi.org/10.1038/sj.gt.3300683
- Received: 06 November 1997
- Accepted: 13 February 1998
- Published: 10 July 1998
- Issue Date: 01 July 1998
- DOI: https://doi.org/10.1038/sj.gt.3300683